Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Silexion Therapeutics Corp (SLXN) had Pre-Tax Income of $-11.91M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.91M |
|
-- |
|
-- |
|
$11.63M |
|
$-11.63M |
|
$-0.28M |
|
|
Pre-Tax Income |
$-11.91M |
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.91M |
|
$-11.63M |
|
$-11.62M |
|
0.13M |
|
0.13M |
|
$-89.60 |
|
$-89.60 |
|
| Balance Sheet Financials | |
$6.64M |
|
$0.03M |
|
$0.58M |
|
$7.21M |
|
$2.76M |
|
$1.57M |
|
$1.85M |
|
$4.61M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
0.31M |
|
| Cash Flow Statement Financials | |
$-10.82M |
|
$-0.01M |
|
$15.64M |
|
$1.27M |
|
$6.08M |
|
$4.80M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
0.38 |
|
0.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-457.63% |
|
-457.63% |
|
-165.10% |
|
-285.59% |
|
$8.32 |
|
$-81.44 |
|
$-81.38 |
|